Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir.
about
P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociceptionA review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practiceEfflux transporters- and cytochrome P-450-mediated interactions between drugs of abuse and antiretrovirals.Interaction between buprenorphine and atazanavir or atazanavir/ritonavir.Drug interactions of clinical importance among the opioids, methadone and buprenorphine, and other frequently prescribed medications: a review.Clinical care of the HIV-infected drug userPharmacokinetic interactions between HIV antiretroviral therapy and drugs used to treat opioid dependence.Pharmacokinetic interactions between buprenorphine and antiretroviral medications.Use of an Acetyl Derivative to Improve GC-MS Determination of Norbuprenorphine in the Presence of High Concentrations of Buprenorphine in Urine.Drug interactions in the management of HIV infection: an update.Pharmacogenomics of CYP3A: considerations for HIV treatment.Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxonePotential drug-drug interactions in HIV-infected children on antiretroviral therapy in Lagos, Nigeria.Methadone, buprenorphine, and street drug interactions with antiretroviral medicationsDrug-Drug Interactions With Antiviral Agents in People Who Inject Drugs Requiring Substitution Therapy.Tipranavir/Ritonavir Induction of Buprenorphine Glucuronide Metabolism in HIV-Negative Subjects Chronically Receiving Buprenorphine/Naloxone
P2860
Q24631289-7CD2BDBB-0445-40BC-BE25-6A0AA22E85AAQ27692040-1C98482A-F015-438C-AD22-5FD03EF0A77BQ35000765-07292BF8-BE9E-422B-93F1-C24BE601327EQ35738878-CD6E88AC-05FC-40FE-B6A3-5437C15F38D1Q35906594-1F7A962F-50A5-40EC-8669-B59540FFAEE6Q36248580-D202CFC1-E827-4D18-9D98-612FF8D4986EQ36543096-3C14BBCA-F5CF-495E-8AC0-171A1182D59FQ36655057-D12D8389-7780-4C21-B9C0-EFD1753720C3Q36948818-003DB008-F643-487A-860F-386E5B13CE9EQ37000733-08361751-4FD3-4154-BDF0-2A5D3D5CC0E3Q37419542-4A81770E-8BF7-4AEF-94F1-9105160917B0Q37425629-91B248BB-02B4-4FBD-9630-7CA9BC1DA667Q37696834-B906E726-0FA8-428D-B6A3-C11CE2A43495Q37763615-C9C68147-9068-4A3C-9D1F-E7FD423E1868Q38435908-45A7823C-9F29-49D4-83E3-EC0311BFF5C3Q58143296-68ED3F62-E678-4A60-9EE6-C741A36952C2
P2860
Three case reports of a clinical pharmacokinetic interaction with buprenorphine and atazanavir plus ritonavir.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Three case reports of a clinic ...... and atazanavir plus ritonavir.
@en
Three case reports of a clinic ...... and atazanavir plus ritonavir.
@nl
type
label
Three case reports of a clinic ...... and atazanavir plus ritonavir.
@en
Three case reports of a clinic ...... and atazanavir plus ritonavir.
@nl
prefLabel
Three case reports of a clinic ...... and atazanavir plus ritonavir.
@en
Three case reports of a clinic ...... and atazanavir plus ritonavir.
@nl
P1433
P1476
Three case reports of a clinic ...... and atazanavir plus ritonavir.
@en
P2093
Frederick L Altice
R Douglas Bruce
P304
P356
10.1097/01.AIDS.0000216384.22432.9A
P407
P577
2006-03-01T00:00:00Z